Amgen 1Q Profit Eases, But Adjusted EPS Tops Views - Fox Business PDF Print
Fox Business
Revenue for the maker of therapeutics in supportive cancer care, nephrology and inflammation was $3.71 billion, up 3% from $3.6 billion a year ago, ahead of average analyst estimates polled by Thomson Reuters of $3.69 billion.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.